Elie G. Hanania

Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer

Robert S. Negrin, K Atkinson, Tom Leemhuis et al. · Biology of Blood and Marrow Transplantation · 2000 · 165 citations · Full text

Medicine, Hematology, Oncology +17

Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy

Elie G. Hanania, Richard E. Giles, J. J. Kavanagh et al. · Proceedings of the National Academy of Sciences · 1996 · 152 citations · Full text

Medicine, Cell Biology, Hematology +14

Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards.

Christopher J. Gerard, K Olsson, Rajeev Ramanathan et al. · PubMed · 1998 · 120 citations

Medicine, Hematology, Molecular Biology +15

Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma

Mauricette Michallet, Thierry Philip, Irène Philip et al. · Experimental Hematology · 2000 · 111 citations · Full text

Medicine, Hematology, Oncology +12

Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit.

Elie G. Hanania, Siqing Fu, Igor B. Roninson et al. · PubMed · 1995 · 81 citations

Medicine, Oncology, Pharmacology +12